Stem Cells @20 UW-Madison
In 1998, UW–Madison developmental biologist James Thomson introduced the world to the first laboratory-derived human embryonic stem cells. His lab’s accomplishment underpins the new field of regenerative medicine, and the all-purpose cells are used worldwide to test drugs, develop treatments for diseases and further our understanding of basic human biology. Twenty years later, UW–Madison remains at the forefront, an internationally recognized leader in stem cell research.
SCRMC Updates
Engineers drawn to stem cells’ abundance, humanity
There was a time when Eric Shusta’s lab was more reliant on the local butcher shop than you might expect. To learn more about the blood-brain barrier — the cellular wall between the open ocean of the bloodstream and the protected confines of the brain — and how to trick the body into letting foreign molecules (like drugs for neurological disease) through the barrier’s gates, Shusta needed brains.
October 18, 2018WARF announces annual grant figures and Innovation Award winners
WARF announces annual grant figures and Innovation Award winners including SCRMC members Lih-Sheng Turng,Mechanical Engineering, and Melissa Skala, Morgridge Institute for Research / Biomedical Engineering.
October 17, 2018Scientists seek to improve quality control for genome editing therapies in the eye
As gene editing therapies for macular degeneration and other visual disorders work their way into clinical trials, the University of Wisconsin–Madison is on the forefront of research into making sure they are safe and effective. …
October 11, 2018Stem Cells @ 20: The Stem Cell and Regenerative Medicine center galvanizes stem cell research
Through the work of the UW-Madison Stem Cell and Regenerative Medicine Center , UW–Madison has remained at the forefront of the field. Launched in May 2007, the center serves as an intellectual and collaborative hub for a broad-based, interdisciplinary research community. Today, more than 600 scientists and students in almost 100 SCMRC labs around campus are working, teaching and studying in the field.
October 2, 2018Jacques Galipeau named associate dean for therapeutics development
SCRMC member Jacques Galipeau, MD, the Don and Marilyn Anderson Professor in Oncology and director of the Program for Advanced Cell Therapy (PACT), became the inaugural associate dean for therapeutics development on September 1. An …
September 20, 2018- More News posts
